Join today and have your say! It’s FREE!
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Post by Magnitudeon Mar 20, 2024 12:00pm
147 Views
Post# 35942941

It takes years to change laws and its already been 50yr

It takes years to change laws and its already been 50yrThe truth is the White House can't really just order rescheduling or descheduling to be done its the DEA with the final decision and even then it could take years its already been 50year for this law so how many times has this industry got its hopes up just to be let down? how many times in just a year? Theres no magic wand that will have this passed this year. Congress is having trouble just passing a budget


Timeline of Events: Tracing the Path Forward

While the exact timeline for the DEA's decision-making process remains fluid, several key events provide insights into the path forward:

  1. Petition Submission: Advocacy groups and stakeholders submit petitions urging the DEA to reevaluate marijuana's classification.

  2. Review and Analysis: The DEA conducts a comprehensive review of scientific literature, medical research, and public feedback to inform its decision-making.

  3. Consultation and Expert Input: The agency solicits input from medical professionals, researchers, and other experts to assess the potential benefits and risks of marijuana rescheduling.

  4. Public Comment Period: A period for public comments allows individuals and organizations to contribute their perspectives and insights on the issue.

  5. Deliberation and Decision: Following thorough analysis and consideration of all pertinent factors, the DEA announces its decision regarding marijuana rescheduling.

    Breaking Down the Timeline for DEA's Decision on Marijuana Rescheduling - Blog (floraflex.com)

<< Previous
Bullboard Posts
Next >>